Daiwa upgraded Edwards Lifesciences (EW) to Outperform from Neutral with an $89 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences Reports Strong Growth and Raises Guidance
- Edwards Lifesciences’ MITRIS Valve Study: A Key Development for Investors
- Edwards Lifesciences price target raised to $101 from $89 at Goldman Sachs
- Edwards Lifesciences price target raised to $95 from $87 at Mizuho
- Early notable gainers among liquid option names on July 25th